Administrative Core
Administrative Core
批准号:
10328139
负责人:
DAVID B. WEINER
金额:
$27.52万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-22 至 2025-08-31
关键词:
2019-nCoVAnimalsBiochemistryBioinformatics Shared ResourceBiometryCommunicationCoronavirusDataDatabasesDecision MakingDevelopmentDoctor of PhilosophyEnsureEventFeedbackFinancial SupportFundingFutureGoalsHumanHuman ResourcesImmunityImmunologistImmunologyIndianaIntellectual PropertyLeadershipLinkMiddle East Respiratory Syndrome CoronavirusMolecularMonitorNucleic Acid VaccinesNucleic AcidsPennsylvaniaPerformancePersonsProgram ReviewsProgress ReportsProtein EngineeringPublicationsReagentReportingResearchResearch Project GrantsResourcesRunningSARS coronavirusSamplingScienceShippingShipsStructural BiologistTeleconferencesTelephoneThe Wistar InstituteTimeLineUnited States National Institutes of HealthUniversitiesUpdateVideoconferencingVirusWorkZoonosesarchive dataarchived dataconflict resolutionexperiencegene therapyhuman coronavirusmeetingsmembernanoparticle deliverynext generationnovel coronavirusnovel vaccinesnucleic acid deliveryopen dataprogramssynthetic nucleic acidtransmission processuniversal coronavirus vaccinevaccine strategyvaccinologyvirologyzoonotic coronavirus
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
The goal of this Program is to develop a next-generation, universal coronavirus synthetic nucleic acid vaccine
employing advancements in nucleic acid delivery of nanoparticles that will provide broad protection against
multiple seasonal and emerging CoV. There are seven CoV known to infect people, 4 human (HCoV-NL63, -
229E, -OC43, -HKU1) and 3 zoonotic that have crossed into humans in the past 20 years (SARS-CoV-1, SARS-
CoV-2, and MERS-CoV). Zoonotic CoV are introduced by cross-transmission events from animals and the most
concerning due to lack of immunity in people. Spread of future related viruses is of concern and new vaccine
strategies are urgently needed that will provide broad protection in people against multiple coronaviruses.
This program brings together the expertise of teams from The Wistar Institute (Drs. Weiner, Kulp, and Patel),
The University of Pennsylvania (Dr. Allman), and Indiana University (Dr. Pallesen). Together, the team has
significant experience in virology, immunology, protein engineering, and molecular and cellular biochemistry.
The Program is organized into 2 Research Projects, overseen by the Administrative Core (AC). Dr. Ami Patel
(The Wistar Institute) will serve as director for the AC.
The goal of the Administrative core (AC), led by Dr. Patel as part of a three-member leadership team consisting
of Dr. Kulp, Weiner and Patel, will provide overall governance and oversight to ensure the Program goals are
met. These goals will be achieved through active program management including administrative and financial
support, project monitoring and reporting, research compliance oversight, team communication, resource
management, conflict resolution, and intellectual property management. In these functions, the AC will be
responsible for overall program performance, personnel, sample distribution, and animal shipping coordination.
The AC will arrange regular team calls for open data discussion and timeline review and organize yearly review
meetings. The AC will arrange calls between the Program Direction, Project Leads and the NIH Program Office
and provide yearly reports on progress for program feedback as well as facilitate publication of findings and
scientific meeting attendance.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
2023 International Society for Vaccines (ISV) Annual Congress, October 22-25, Lausanne, Switzerland
-
批准号:10754840
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2023
-
负责人:DAVID B. WEINER
-
依托单位:
Administrative Core
-
批准号:10589586
-
项目类别:
-
资助金额:$72.69万
-
财政年份:2022
-
负责人:DAVID B. WEINER
-
依托单位:
Rapid, single-dose coronavirus vaccines via DNA-launched nanoparticles and genetic adjuvants for durable anti-coronavirus immunity
-
批准号:10328141
-
项目类别:
-
资助金额:$110.71万
-
财政年份:2022
-
负责人:DAVID B. WEINER
-
依托单位:
Synthetic DNA-launched and adjuvanted Env immunogens for HIV
-
批准号:10589585
-
项目类别:
-
资助金额:$449.79万
-
财政年份:2022
-
负责人:DAVID B. WEINER
-
依托单位:
Design and optimization of DL-NLTs and molecular adjuvants to increase potency and promote NAb formation in vivo
-
批准号:10589587
-
项目类别:
-
资助金额:$142.76万
-
财政年份:2022
-
负责人:DAVID B. WEINER
-
依托单位:
Novel DNA encoded monoclonal antibodies (DMAbs) for control of Antimicrobial Resistant (AMR) Pseudomonas aeruginosa infection
-
批准号:10459450
-
项目类别:
-
资助金额:$97.92万
-
财政年份:2019
-
负责人:DAVID B. WEINER
-
依托单位:
Novel DNA encoded monoclonal antibodies (DMAbs) for control of Antimicrobial Resistant (AMR) Pseudomonas aeruginosa infection
-
批准号:10004562
-
项目类别:
-
资助金额:$115.33万
-
财政年份:2019
-
负责人:DAVID B. WEINER
-
依托单位:
Novel DNA encoded monoclonal antibodies (DMAbs) for control of Antimicrobial Resistant (AMR) Pseudomonas aeruginosa infection
-
批准号:10228693
-
项目类别:
-
资助金额:$95.06万
-
财政年份:2019
-
负责人:DAVID B. WEINER
-
依托单位:
Administration
-
批准号:9261462
-
项目类别:
-
资助金额:$21.39万
-
财政年份:2017
-
负责人:DAVID B. WEINER
-
依托单位:
Multivalent DNA vaccine-mediated protection against Tuberculosis
-
批准号:10297846
-
项目类别:
-
资助金额:$86.53万
-
财政年份:2017
-
负责人:DAVID B. WEINER
-
依托单位:
Multivalent DNA vaccine-mediated protection against Tuberculosis
-
批准号:10054982
-
项目类别:
-
资助金额:$90.84万
-
财政年份:2017
-
负责人:DAVID B. WEINER
-
依托单位:
Synthetic DNA & Novel Env Vaccine for HIV
-
批准号:9024416
-
项目类别:
-
资助金额:$342.45万
-
财政年份:2015
-
负责人:DAVID B. WEINER
-
依托单位:
Synthetic DNA & Novel Env Vaccine for HIV
-
批准号:9261455
-
项目类别:
-
资助金额:$333.75万
-
财政年份:2015
-
负责人:DAVID B. WEINER
-
依托单位:
Development of a Universal Influenza Seasonal Vaccine
-
批准号:8721834
-
项目类别:
-
资助金额:$36.08万
-
财政年份:2010
-
负责人:DAVID B. WEINER
-
依托单位:
Development of a Universal Influenza Seasonal Vaccine
-
批准号:8317646
-
项目类别:
-
资助金额:$111.31万
-
财政年份:2010
-
负责人:DAVID B. WEINER
-
依托单位:
Development of a Universal Influenza Seasonal Vaccine
-
批准号:8525084
-
项目类别:
-
资助金额:$54.8万
-
财政年份:2010
-
负责人:DAVID B. WEINER
-
依托单位:
Development of a Universal Influenza Seasonal Vaccine
-
批准号:8143485
-
项目类别:
-
资助金额:$42.85万
-
财政年份:2010
-
负责人:DAVID B. WEINER
-
依托单位:
Development of a Universal Influenza Seasonal Vaccine
-
批准号:9352656
-
项目类别:
-
资助金额:$10.75万
-
财政年份:2010
-
负责人:DAVID B. WEINER
-
依托单位:
Development of a Universal Influenza Seasonal Vaccine
-
批准号:8017652
-
项目类别:
-
资助金额:$47.65万
-
财政年份:2010
-
负责人:DAVID B. WEINER
-
依托单位:
Training in Vaccine & Immune Therapeutics
-
批准号:7503022
-
项目类别:
-
资助金额:$19.41万
-
财政年份:2008
-
负责人:DAVID B. WEINER
-
依托单位:
海外基金